Vivos Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Vivos Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Vivos Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -99 %, a 16.9% increase year-over-year.
  • Vivos Therapeutics, Inc. annual Return On Assets for 2023 was -105 %, a 5.55% increase from 2022.
  • Vivos Therapeutics, Inc. annual Return On Assets for 2022 was -111 %, a 95.1% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -99 +20.2 +16.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -134 -24.4 -22.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -105 +6.15 +5.55% Oct 1, 2023 Dec 31, 2023
Q3 2023 -112 -17.4 -18.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -119 -40.9 -52.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -110 -50.8 -86% Jan 1, 2023 Mar 31, 2023
Q4 2022 -111 -54 -95.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -94.9 -37.9 -66.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -78.3 Apr 1, 2022 Jun 30, 2022
Q1 2022 -59.1 Jan 1, 2022 Mar 31, 2022
Q4 2021 -56.8 Oct 1, 2021 Dec 31, 2021
Q3 2021 -57 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.